179 related articles for article (PubMed ID: 38240957)
1. Comparative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications.
Wang Y; Wang X; Chen J; Huang S; Huang Y
Updates Surg; 2024 Jun; 76(3):949-962. PubMed ID: 38240957
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.
Sorrentino L; Guaglio M; Battaglia L; Bonfanti G; Vitellaro M; Bianchi AC; Milione M; Belli F
Int J Colorectal Dis; 2019 Dec; 34(12):2161-2169. PubMed ID: 31741026
[TBL] [Abstract][Full Text] [Related]
3. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
4. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
[TBL] [Abstract][Full Text] [Related]
5. Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?
Song JH; Yu M; Kang KM; Lee JH; Kim SH; Nam TK; Jeong JU; Jang HS; Lee JW; Jung JH
Radiother Oncol; 2019 Apr; 133():125-131. PubMed ID: 30935568
[TBL] [Abstract][Full Text] [Related]
6. Impact of Postoperative Chemoradiotherapy versus Chemotherapy Alone on Recurrence and Survival in Patients with Stage II and III Upper Rectal Cancer: A Propensity Score-Matched Analysis.
Song C; Song S; Kim JS; Oh HK; Kim DW; Lee KW; Kim JH; Eom KY; Kim IA; Kang SB
PLoS One; 2015; 10(4):e0123657. PubMed ID: 25902069
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.
Lee ES; Kim MJ; Park SC; Hur BY; Hyun JH; Chang HJ; Baek JY; Kim SY; Kim DY; Oh JH
Eur Radiol; 2018 Feb; 28(2):496-505. PubMed ID: 28786006
[TBL] [Abstract][Full Text] [Related]
8. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
[TBL] [Abstract][Full Text] [Related]
9. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
10. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
11. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
12. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
[No Abstract] [Full Text] [Related]
13. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
[TBL] [Abstract][Full Text] [Related]
14. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response.
You KY; Huang R; Zhang LN; Ding PR; Xiao WW; Qiu B; Chang H; Zeng ZF; Pan ZZ; Gao YH
J Cancer Res Clin Oncol; 2015 Apr; 141(4):719-28. PubMed ID: 25296560
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).
Kondo K; Matsusaka S; Ishihara S; Horie H; Uehara K; Oguchi M; Murafushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Fujii M; Nakajima T
Radiother Oncol; 2019 May; 134():199-203. PubMed ID: 31005216
[TBL] [Abstract][Full Text] [Related]
17. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
18. Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative Chemoradiation.
Deidda S; Elmore U; Rosati R; De Nardi P; Vignali A; Puccetti F; Spolverato G; Capelli G; Zuin M; Muratore A; Danna R; Calabrò M; Guerrieri M; Ortenzi M; Ghiselli R; Scabini S; Aprile A; Pertile D; Sammarco G; Gallo G; Sena G; Coco C; Rizzo G; Pafundi DP; Belluco C; Innocente R; Degiuli M; Reddavid R; Puca L; Delrio P; Rega D; Conti P; Pastorino A; Zorcolo L; Pucciarelli S; Aschele C; Restivo A
JAMA Surg; 2021 Dec; 156(12):1141-1149. PubMed ID: 34586340
[TBL] [Abstract][Full Text] [Related]
19. Total neoadjuvant therapy for locally advanced rectal cancer: a three-group propensity score matched study.
Zhou J; Huang J; Zhou Z; Deng X; Wu Q; Wang Z
Int J Colorectal Dis; 2024 Mar; 39(1):38. PubMed ID: 38492080
[TBL] [Abstract][Full Text] [Related]
20. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
